CIK 0001703057 · Large accelerated filer
AbCellera Biologics Inc.
Sign in to watch- Ticker
- ABCL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- British Columbia, Canada
- Entity type
- operating
- Phone
- (604) 559-9005
- Business address
- 150 W 4TH AVENUE, VANCOUVER, British Columbia, Canada, V5Y 1G6
- 8-K Event Regulation FD disclosure
- 4 Option exercise Chief Operating Officer acquired 83,333 shares (option exercise)
- 4 Option exercise Chief Executive Officer acquired 224,500 shares (option exercise)
- 4 Open-market buy Chief Financial Officer bought 67,500 shares at an average $14.71 ($993,130)
- 4 Open-market buy 10% owner bought 202,960 shares at $14.76 ($2,995,913)
- 424B3 Offering Prospectus
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Regulation FD disclosure
- 424B3 Offering Prospectus
- 8-K Event Regulation FD disclosure
- 4 Insider Changes in Ownership
- 424B3 Offering Prospectus
- 8-K Event Other events
- 424B3 Offering Prospectus
- 8-K Event Other events
- 4 Option exercise Director acquired 270,000 shares (option exercise)
- 4 Option exercise Chief Technology Officer acquired 875,000 shares (option exercise)
- 4 Open-market sale Director sold 300,000 shares at an average $16.94 ($5,082,253)
- 4 Open-market buy Director bought 6,000 shares at $17.23 ($103,380)
- 424B3 Offering Prospectus
Page 12 of 17 · 325 filings